MD Anderson Cancer Center Offers an Essential 6-Day Course: Mastering Hematology & Oncology for ABIM Success
MD Anderson Cancer Center shared an inviting post on X:
”A virtual live-streaming course will offer comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.”
To learn more and register, follow the link.
A 6-day virtual course by MD Anderson Cancer Center and Baylor College of Medicine offers a comprehensive review of current practices in managing blood disorders and malignancies, tailored to help participants prepare for the ABIM certification in Hematology and Medical Oncology.
The program covers key updates in pharmacology, molecular genetics, risk assessment, and radiation oncology.
By the end of the course, participants will be equipped to:
- Confidently prepare for hematology and medical oncology subspecialty and recertification exams.
- Apply up-to-date standards of care in treating cancer, blood disorders, and malignancies.
- Demonstrate comprehensive knowledge in hematology and medical oncology.
- Integrate recent advances into the management of hematologic and oncologic patients.
Don’t miss your chance, apply now!
Stay informed on the latest conferences, courses, and webinars—read Hemostasis Today for all the updates!
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells